US Patent 11110163 Heat stable vaccines
Patent 11110163 was granted and assigned to Inventprise Llc on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+533 characters)
Article
Patent abstract
The invention is directed to an oral vaccine composed of a micronized freeze-dried rotavirus particle suspension with buffering excipients in a non-aqueous liquid. This IVT-06 formulation has imparted heat stability by protecting the virus at temperatures of 30° C. and 40° C. for at least twelve months. Extrapolations from the 12-month stability data indicate a shelf life of more than two years at 30° C., and six months at 50° C. In addition, for ease of administration, the formulated dose has a volume of 0.5 mL.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Ivan A. Olave0
Subhash V. Kapre0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111101630
Date of Patent
September 7, 2021
0Patent Application Number
201909160
Date Filed
September 16, 2019
0Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11110163 Heat stable vaccines
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11110163
Date of patent
September 7, 2021
Patent application number
20190916
Date Filed
September 16, 2019
Find more entities like US Patent 11110163 Heat stable vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
